Study of the effect of packaged drug sets for eradication of Helicobacter pylori on the improvement of adherence.

Study of the effect of packaged drug sets for eradication of Helicobacter pylori on the improvement of adherence. - Study of the effect of packaged drug sets for eradication of Helicobacter pylori on the improvement of adherence.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013582

Enrollment

Registered

2014-04-01

Start date

2013-06-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrophic gastritis, gastric ulcer, duodenal ulcer, MALToma, ITP, and early gastric cancer (post endoscopic therapy)

Interventions

eradication therapy for 7days using packaged drug sets eradication therapy for 7days using non packaged drug sets

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients over 20 years old who have any one of atrophic gastritis, gastric ulcer, duodenal ulcer, post endoscopit therapeutic gastric cancer, ITP, and gastric MALToma

Exclusion criteria

Exclusion criteria: patients who have any allergy to drugs patients who have untreated gastric cancer pregnant woman nursing woman patient who underwent upper gastrointestinal surgery

Design outcomes

Primary

Measure	Time frame
Compliance and comprehension of adverse effects	—

Secondary

Measure	Time frame
success rate of eradication	—

Countries

Japan

Contacts

Public ContactMasahito Aimi

Shimane University Faculty of medicine Department of Gastroenterology and Hepatology

aimi@med.shimane-u.ac.jp0853-23-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026